Overview
PROF market data
Price History
PROF price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.41 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.05 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -206.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $5.23 – $12.40 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $376.3M · P/B 3.23 · P/S 14.35.
Company News
Profound Medical Affirms FY2026 Sales Guidance of $25.000M vs $26.858M EstBenzinga · Aug 6, 2026, 8:50 PM
Profound Medical Q2 EPS $(0.26), Inline, Sales $2.483M Miss $5.500M EstimateBenzinga · Aug 6, 2026, 8:20 PM
8-K filing — Profound Medical Corp. (PROF)SEC EDGAR · Jul 24, 2026, 3:58 PM